Paul Carter

Mr. Carter, aged 60, has been the Senior Independent Non-executive Director of the Company since 2017. He is also Chairman of the Remuneration Committee and a member of the Audit Committee and Technical Committee of the Company. He was a member of the Nomination Committee of the Company from April 2019 to December 2020. He has more than 26 years of experience in the pharmaceutical industry. From 2006 to 2016, Mr. Carter served in various senior executive roles at Gilead Sciences, Inc. (“Gilead”), a research-based biopharmaceutical company, with the last position as Executive Vice President, Commercial Operations. In this role, Mr. Carter headed the worldwide commercial organization responsible for the launch and commercialization of all of Gilead’s products. Prior to joining Gilead, he spent 14 years with GlaxoSmithKline plc (GSK) and its group companies, with the last position as Regional Head of the International Business in Asia. He is currently a director of Mallinckrodt plc and Immatics N.V. He is chairman of Evox Therapeutics and a retained advisor to several firms active in the life sciences sector. He was formerly a director of Alder Biopharmaceuticals, Inc.

Mr. Carter holds a degree in Business Studies from the Ealing School of Business and Management (now merged into the University of West London) and is a Fellow of the Chartered Institute of Management Accountants in the United Kingdom.